Performance of RGNX Regenxbio | -31.4% in 12m

Compare RGNX with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?

Compare Regenxbio with its related Sector/Index XBI

Compare Regenxbio with its related Sector/Index XBI

Performance Duell RGNX vs XBI

TimeFrame RGNX XBI
1 Day 0.47% 1.02%
1 Week 17.2% 7.91%
1 Month -2.89% 5.61%
3 Months -29.4% 12.40%
6 Months -15.6% 9.58%
12 Months -31.4% 15.55%
YTD -30.4% 9.81%
Rel. Perf. 1m -1.73
Rel. Perf. 3m -4.37
Rel. Perf. 6m -2.66
Rel. Perf. 12m -2.66

Is Regenxbio a good stock to buy?

No, based on ValueRay Fundamental Analyses, Regenxbio (NASDAQ:RGNX) is currently (July 2024) a stock to sell. It has a ValueRay Fundamental Rating of -69.01 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RGNX as of July 2024 is 9.85. This means that RGNX is currently overvalued and has a potential downside of -22.87% (Sold with Premium).

Is RGNX a buy, sell or hold?

  • Strong Buy: 6
  • Buy: 5
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
Regenxbio has received a consensus analysts rating of 4.42. Therefor, it is recommend to buy RGNX.
Values above 0%: RGNX is performing better - Values below 0%: RGNX is underperforming

Compare RGNX with Broad Market Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY 16.20% -6.67% -33.82% -57.33%
US NASDAQ 100 QQQ 17.43% -7.42% -36.77% -61.60%
US Dow Jones Industrial 30 DIA 15.48% -6.38% -23.03% -49.29%
German DAX 40 DBXD 15.58% -3.57% -27.41% -46.80%
UK FTSE 100 ISFU 14.95% -4.52% -27.84% -44.91%
Shanghai Shenzhen CSI 300 CSI 300 14.94% -1.53% -21.35% -21.01%
Hongkong Hang Seng HSI 12.61% -2.45% -13.80% -17.07%
Japan Nikkei 225 EXX7 14.98% -6.72% -22.87% -47.75%
India NIFTY 50 INDA 16.44% -7.28% -29.83% -59.45%
Brasil Bovespa EWZ 14.48% -9.90% -3.29% -27.82%

RGNX Regenxbio vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC 18.81% -5.19% -33.16% -61.71%
Consumer Discretionary XLY 16.00% -9.73% -26.15% -41.27%
Consumer Staples XLP 17.07% -4.62% -23.58% -39.05%
Energy XLE 16.69% -4.82% -26.85% -46.47%
Financial XLF 15.14% -7.15% -29.18% -56.05%
Health Care XLV 14.49% -4.81% -21.91% -46.31%
Industrial XLI 14.72% -4.06% -27.09% -47.13%
Materials XLB 14.20% -4.11% -24.96% -42.18%
Real Estate XLRE 12.75% -8.34% -18.46% -39.11%
Technology XLK 16.76% -6.96% -37.63% -63.57%
Utilities XLU 13.21% -5.58% -29.98% -42.91%
Aerospace & Defense XAR 15.15% -3.96% -25.89% -49.62%
Biotech XBI 9.25% -8.50% -25.18% -46.93%
Homebuilder XHB 6.34% -6.07% -30.92% -61.94%
Retail XRT 12.18% -4.10% -28.43% -50.66%

RGNX Regenxbio vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO 18.46% -8.51% -33.58% -51.91%
Natural Gas UNG 17.80% 22.70% 27.58% 11.38%
Gold GLD 16.17% -6.80% -33.21% -54.26%
Silver SLV 18.42% -6.92% -48.30% -54.77%
Copper CPER 18.72% -4.50% -37.45% -50.87%

Returns of RGNX vs. Yields & Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT 15.67% -4.75% -14.88% -27.72%
iShares High Yield Corp. Bond HYG 16.45% -4.21% -19.12% -41.48%
Does Regenxbio outperform its market, is RGNX a Sector Leader?
No, over the last 12 months Regenxbio (RGNX) made -31.38%, while its related Sector, the SPDR S&P Biotech (XBI) made 15.55%.
Over the last 3 months RGNX made -29.41%, while XBI made 12.40%.
Period RGNX XBI S&P 500
1 Month -2.89% 5.61% 3.78%
3 Months -29.41% 12.40% 9.97%
12 Months -31.38% 15.55% 25.95%